FLUDEOXYGLUCOSE (F-18)
Google image searchProduct monograph
Active ingredient
fludeoxyglucose 18f, 232 GBQ/VIAL
DIN: 02462354
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: >0.5 GBQ
Schedule: Schedule C
Company: LAWSON HEALTH RESEARCH INSTITUTE
Date: 17-OCT-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX04 — FLUDEOXYGLUCOSE (18F) (ATC/DDD)
